A marine sponge associated fungal metabolite monacolin X suppresses angiogenesis by down regulating VEGFR2 signaling.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
23 Aug 2019
23 Aug 2019
Historique:
received:
10
07
2019
accepted:
08
08
2019
entrez:
9
5
2022
pubmed:
27
8
2019
medline:
27
8
2019
Statut:
epublish
Résumé
Cancer is one of the leading causes of global death and there is an urgent need for the development of cancer treatment; targeting VEGFR2 could be one of the promising therapies. In the present study, previously isolated marine fungal metabolite monacolin X, suppresses
Identifiants
pubmed: 35528587
doi: 10.1039/c9ra05262c
pii: c9ra05262c
pmc: PMC9070443
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26646-26667Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
The corresponding author declare that no conflicts of interest exist.
Références
Development. 2002 Feb;129(4):973-82
pubmed: 11861480
Food Sci Nutr. 2013 Jan;1(1):74-82
pubmed: 24804016
J Pharm Pharmacol. 2010 Jan;62(1):145-51
pubmed: 20723011
Molecules. 2016 Sep 21;21(9):
pubmed: 27657036
Mol Biol Rep. 2018 Dec;45(6):2641-2651
pubmed: 30414102
Cell Signal. 2007 Oct;19(10):2003-12
pubmed: 17658244
Angiogenesis. 1999;3(4):353-9
pubmed: 14517415
Mar Drugs. 2015 Dec 22;14(1):1
pubmed: 26703630
Breast Cancer Res Treat. 2005 Jan;89(2):135-43
pubmed: 15692755
Oncotarget. 2016 Jan 19;7(3):3533-47
pubmed: 26657289
Mediators Inflamm. 2013;2013:127170
pubmed: 23983401
Trends Biochem Sci. 1997 Jul;22(7):251-6
pubmed: 9255066
Cell. 2011 Sep 16;146(6):873-87
pubmed: 21925313
Sci Rep. 2016 Mar 15;6:23077
pubmed: 26975752
Cell. 1994 Oct 21;79(2):185-8
pubmed: 7525076
Organogenesis. 2010 Apr-Jun;6(2):107-14
pubmed: 20885857
J Med Chem. 2018 Jan 11;61(1):140-157
pubmed: 29189002
J Clin Invest. 2006 Jun;116(6):1596-605
pubmed: 16680193
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
Biochem Biophys Res Commun. 2009 May 8;382(3):503-7
pubmed: 19303400
Circulation. 1998 Mar 24;97(11):1087-94
pubmed: 9531256
Mar Drugs. 2013 Mar 15;11(3):903-33
pubmed: 23502698
Am J Vet Res. 1990 Jun;51(6):905-8
pubmed: 2368946
Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
pubmed: 16633338
Bioinformation. 2015 Dec 31;11(12):535-42
pubmed: 26770027
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Curr Opin Drug Discov Devel. 2004 Jul;7(4):396-403
pubmed: 15338948
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
PLoS One. 2013 Nov 14;8(11):e80292
pubmed: 24244672
Am J Psychiatry. 1989 Sep;146(9):1237-8
pubmed: 2764193
Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):218-32
pubmed: 22216781
Mar Drugs. 2014 Jan 16;12(1):279-99
pubmed: 24441613
Mol Cell Biochem. 2017 Oct;434(1-2):7-15
pubmed: 28397014
Cell Cycle. 2006 Mar;5(5):512-8
pubmed: 16552185
Int J Oncol. 2014 Mar;44(3):745-60
pubmed: 24366449
Curr Drug Targets. 2010 Aug;11(8):1000-17
pubmed: 20426765
Int J Oncol. 2015 Apr;46(4):1619-28
pubmed: 25673059
Phytomedicine. 2015 Jan 15;22(1):103-10
pubmed: 25636878
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10857-62
pubmed: 11553814
PLoS One. 2010 Jul 29;5(7):e11822
pubmed: 20686605
Biomed Pharmacother. 2017 Aug;92:207-214
pubmed: 28544934
Mar Drugs. 2010 Oct 15;8(10):2673-701
pubmed: 21116414
Biochem Biophys Res Commun. 2008 Oct 24;375(3):287-91
pubmed: 18680722
Expert Opin Drug Discov. 2015 May;10(5):449-61
pubmed: 25835573
PLoS One. 2013 Jul 05;8(7):e68566
pubmed: 23861918
Cold Spring Harb Perspect Biol. 2013 Oct 01;5(10):a009092
pubmed: 24086040
Nature. 2005 Dec 15;438(7070):932-6
pubmed: 16355210
RSC Adv. 2019 Feb 18;9(11):5878-5890
pubmed: 35517301
Med Res Rev. 2006 Jul;26(4):483-530
pubmed: 16652370
Dev Biol. 1995 Jul;170(1):39-49
pubmed: 7601314
Dev Biol. 1997 Mar 1;183(1):37-48
pubmed: 9119113
PLoS One. 2012;7(8):e43711
pubmed: 22937084
Oncotarget. 2018 Jan 10;9(62):31958-31970
pubmed: 30174789
Cancer Res. 1996 May 1;56(9):2013-6
pubmed: 8616842
J Cancer Res Ther. 2015 Jul-Sep;11(3):597-605
pubmed: 26458588
Cancer Res. 2000 Jan 15;60(2):203-12
pubmed: 10667560
Eur J Cancer. 2004 May;40(7):1066-72
pubmed: 15093584
FASEB J. 2002 Feb;16(2):261-3
pubmed: 11772945
BMC Biol. 2011 Oct 28;9:71
pubmed: 22035460
Cell Prolif. 2016 Dec;49(6):678-697
pubmed: 27641938
PLoS One. 2013 Aug 15;8(8):e71347
pubmed: 23977023
Oncotarget. 2016 Dec 13;7(50):82820-82835
pubmed: 27756875
Molecules. 2018 Mar 02;23(3):
pubmed: 29498688
Cell. 2002 Aug 9;110(3):289-92
pubmed: 12176316
Trends Pharmacol Sci. 2006 Jun;27(6):297-309
pubmed: 16697473
Curr Opin Investig Drugs. 2003 Jun;4(6):667-74
pubmed: 12901224
Drug Des Devel Ther. 2015 Aug 06;9:4397-412
pubmed: 26273199
Angiogenesis. 2011 Sep;14(3):355-69
pubmed: 21667138
Angiogenesis. 2005;8(3):197-204
pubmed: 16328160
Blood. 2006 Jul 1;108(1):160-6
pubmed: 16537812
Angiogenesis. 2008;11(3):245-56
pubmed: 18330714
Int J Mol Sci. 2014 Sep 11;15(9):15994-6011
pubmed: 25216334
Sci Rep. 2016 Oct 25;6:35783
pubmed: 27779188
J Med Chem. 2012 Mar 8;55(5):1858-67
pubmed: 22320343